IMUGENE LIMITED — Capital/Financing Update 2016

Oct 18, 2016

MARKET RELEASE

19 October 2016

Imugene Limited

TRADING HALT

The securities of Imugene Limited (the “Company”) will be placed in Trading Halt Session State at the request of the Company, pending the release of an announcement by the Company. Unless ASX decides otherwise, the securities will remain in Trading Halt Session State until the earlier of the commencement of normal trading on Friday, 21 October 2016 or when the announcement is released to the market.

Security Code: IMU

Dean Litis

PRINCIPAL ADVISER, LISTINGS COMPLIANCE (MELBOURNE)

Level 4, North Tower, Rialto www.asx.com.au 525 Collins Street Customer service 13 12 79 Melbourne VIC 3000

ASX Compliance Pty Limited ABN 26 087 780 489

==> picture [175 x 58] intentionally omitted <==

19 October 2016

Imugene Limited ACN 009 179 551 Suite 1, 1233 High Street Armadale VIC 3142

Dean Litis ASX Compliance Pty Ltd Melbourne VIC

Dear Mr. Litis

**Trading

Halt Request**

Pursuant to ASX Listing Rule 17.1, Imugene Limited (Company) requests a trading halt pending an announcement in relation to a proposed capital raising.

The trading halt will remain in place until the earlier of the commencement of normal trading on Friday 21 October 2016, or until the release of the announcement in respect of the above matter.

The Company is not aware of any reason why the trading halt should not be granted. Yours faithfully

==> picture [55 x 54] intentionally omitted <==

Justyn Stedwell Company Secretary Imugene Limited

IMUGENE LIMITED Telephone +61 3 9824 5254 Fax +61 3 9822 7735 Website www.imugene.com